Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country

Golčić, Marin; Tomaš, Ilijan; Stevanović, Aleksandra; Golčić, Goran; Dobrila-Dintinjana, Renata; Erić, Suzana; Šambić-Penc, Mirela; Marinac, Martina Baretić; Gović-Golčić, Lidija; Majnarić, Tea

doi:10.3390/clinpract11030067

Cited by 5 publications

(8 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our finding that women with recent breast cancer diagnoses significantly reduced their smoking behavior is quite different than the results in Ref. [2]. The differential impact of the time of diagnosis on smoking behavior could arise from a few sources.…”

Section: Discussioncontrasting

confidence: 99%

Lifestyle choices among women with breast cancer in the United States

Michel,

Sovinsky,

Stern

2024

Public Health Challenges

View full text Add to dashboard Cite

IntroductionBreast cancer is a common form of cancer for women. The goal of this research was to estimate how a breast cancer diagnosis affects a woman's decisions about smoking, alcohol use, and exercise.MethodsUsing data from the Panel Study of Income Dynamics on breast cancer diagnosis and lifestyle choices, we estimated how being diagnosed influences smoking, drinking, and exercising habits for more than 8000 women over the period 1999–2011.ResultsControlling for unobserved heterogeneity, persistence in behaviors, and correlation across behaviors, we found that the impact of a diagnosis had a different effect on smoking, drinking, and exercising behaviors. Furthermore, the impact depended upon the recency of the diagnosis. Recently diagnosed women exercised and smoked less—an average woman in our sample reduced exercise by 19% and smoking by 1%. However, women with breast cancer did not change their drinking habits relative to healthy women.ConclusionsA diagnosis of breast cancer impacts lifestyle choices. Women who were diagnosed with breast cancer in the last 5 years exercised and smoked less but did not change their alcohol consumption after a breast cancer diagnosis regardless of when the diagnosis was made. Our approach provides insight into what extent women who are faced with negative information about life expectancy take this into consideration when deciding to engage in risky behaviors that might further affect their survival. Whether to engage in physical activity, drink alcohol, or smoke are choices associated with how to live.

show abstract

Section: Discussioncontrasting

confidence: 99%

Lifestyle choices among women with breast cancer in the United States

Michel,

Sovinsky,

Stern

2024

Public Health Challenges

View full text Add to dashboard Cite

show abstract

“…Furthermore, evidence shows that most smoker patients with cancer do not feel ready to quit after the diagnosis and there is still of subset of smoker patients with cancer who are not even recommended by their physicians to quit smoking. [28][29][30][31] Several biologically plausible mechanisms have been suggested by which smoking can reduce survival in patients with cancer; cigarette smoke contains many carcinogens and mutagens that can directly affect tumor cells and increase their proliferation, migration, invasion, and angiogenesis. 32 Furthermore, smoking can impair the immune response to malignant growth, 32,33 affect the response to and complications from some cancer treatments, 34 and accelerate other illnesses including cardiovascular and other chronic diseases in patients with cancer.…”

Section: Discussionmentioning

confidence: 99%

Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study

Sheikh

Moukeria²,

Zahed

et al. 2023

JCO

View full text Add to dashboard Cite

PURPOSE To investigate whether postdiagnosis smoking cessation may affect the risk of death and disease progression in patients with renal cell carcinoma (RCC) who smoked at the time of diagnosis. METHODS Two hundred twelve patients with primary RCC were recruited between 2007 and 2016 from the Urological Department in N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia. Upon enrollment, a structured questionnaire was completed, and the patients were followed annually through 2020 to repeatedly assess their smoking status and disease progression. Survival probabilities and hazards for all-cause and cancer-specific mortality and disease progression were investigated using extended the Kaplan-Meier method, time-dependent Cox proportional hazards regression, and Fine-Gray competing-risk models. RESULTS Patients were followed for a median of 8.2 years. During this time, 110 cases of disease progression, 100 total deaths, and 77 cancer-specific deaths were recorded. Eighty-four patients (40%) quit smoking after diagnosis. The total person-years at risk for this analysis were 748.2 for continuing smoking and 611.2 for quitting smoking periods. At 5 years of follow-up, both overall survival (85% v 61%) and progression-free survival (80% v 57%) rates were higher during the quitting than continuing smoking periods (both P < .001). In the multivariable time-dependent models, quitting smoking was associated with lower risk of all-cause mortality (hazard ratio [HR], 0.51; 95% CI, 0.31 to 0.85), disease progression (HR, 0.45; 95% CI, 0.29 to 0.71), and cancer-specific mortality (HR, 0.54; 95% CI, 0.31 to 0.93). The beneficial effect of quitting smoking was evident across all subgroups, including light smokers versus moderate-heavy smokers and those with early-stage versus late-stage tumors. CONCLUSION Quitting smoking after RCC diagnosis may significantly improve survival and reduce the risk of disease progression and cancer mortality among patients who smoke.

show abstract

“…Des analyses supplémentaires exclurent les utilisateurs d'autres produits contenant du tabac ou de la nicotine, surveillèrent un plus grand nombre de variables, restreignirent l'analyse des modifications pour un produit particulier aux personnes n'ayant jamais fumé un autre produit ou focalisèrent leur attention sur les modifications se produisant après l'appari-tion des troubles. Résultats: Dans les analyses principales, l'apparition de chaque trouble fut indicatrice d'une augmentation significative des taux généraux d'initiation au vapotage, avec des rapport des cotes au plus haut dans le cas des affections respiratoires majeures (2,86, intervalle de confiance de 95%, 2,10-3,90) et des cancers (2,51,1,14). Chaque apparition était aussi un indicateur de taux plus élevés d'initiation à la cigarette; toutefois, les rapport des cotes étaient inférieurs à ceux relatifs à l'initiation au vapotage et n'étaient significatifs que pour les troubles cardiovasculaires (1,65, 1,31-2,08), pour l'hypertension artérielle (1,34, 1,13-1,58) et pour toutes les affections majeures liées au tabagisme (1,35,1,62).…”

Section: Resumeunclassified

Relating Onset of Health Conditions to Changes in Tobacco/Nicotine Use — Analyses based on the U.S. PATH Study *

P¹,

Fry²

2023

Contributions to Tobacco &Amp; Nicotine Research

View full text Add to dashboard Cite

1. SUMMARY Introduction Evidence is limited on how the onset of health conditions affects tobacco/nicotine use. We report analyses from adults in the U.S. PATH study relating changes in established cigarette and/or e-cigarette use between Waves 1 and 4 to onset of conditions in Waves 2 or 3. Methods Nine conditions had sufficient onsets for analysis. The main analyses adjusted for sex and age. Additional analyses excluded other tobacco/nicotine product users, controlled for more variables, restricted changes in one product to never users of the other, or restricted attention to changes occurring after onset of the condition. Results In the main analyses, onset of each condition predicted significantly increased overall e-cigarette initiation rates, with highest odds ratios (OR) for any major respiratory condition (2.86, 95% confidence interval (CI) 2.10–3.90) and cancer (2.51, 1.52–4.14). Each onset also predicted higher cigarette smoking initiation rates, but ORs were lower than for e-cigarette initiation, and only significant for any cardiovascular condition (1.65, 1.31–2.08), high blood pressure (1.34, 1.13–1.58), and any major smoking-related condition (1.35, 1.12–1.62). For quitting smoking only six conditions showed increased ORs, significant only for high cholesterol (1.29, 1.02–1.62). The additional analyses generally confirmed these patterns. Relationships with re-initiating cigarettes or becoming dual users of cigarettes and e-cigarettes were inconsistent. Onset of conditions also tended to reduce amount smoked by smokers. Conclusions While PATH is nationally representative, its sample size does not always allow precise estimates. There is concern about accuracy of statements by some older participants claiming to be Wave 1 never smokers but Wave 4 ever smokers. Nevertheless the previously unreported association between onset of the health conditions and e-cigarette initiation (which mainly occurs in Wave 1 cigarette smokers) appears real. [Contrib. Tob. Nicotine Res. 32 (2023) 1–10]

show abstract

Smoking Cessation after a Cancer Diagnosis: A Cross-Sectional Analysis in the Setting of a Developing Country

Cited by 5 publications

References 19 publications

Lifestyle choices among women with breast cancer in the United States

Lifestyle choices among women with breast cancer in the United States

Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study

Relating Onset of Health Conditions to Changes in Tobacco/Nicotine Use — Analyses based on the U.S. PATH Study *

Contact Info

Product

Resources

About